Next Article in Journal
Development of Bioresponsive Poloxamer-Based Self-Nanoemulsifying System for Enhanced Febuxostat Bioavailability: Solidification Strategy Using I-Optimal Approach
Previous Article in Journal
Fluorinated Rh(I)–NHC Compounds as Potential Antibacterials Against Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates Producing ESBL
Previous Article in Special Issue
Characterisation and In Vitro Drug Release Profiles of Oleanolic Acid- and Asiatic Acid-Loaded Solid Lipid Nanoparticles (SLNs) for Oral Administration
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(8), 974; https://doi.org/10.3390/pharmaceutics17080974
Action Date Notes Link
article xml file uploaded 28 July 2025 10:45 CEST Original file -
article xml uploaded. 28 July 2025 10:45 CEST Update https://www.mdpi.com/1999-4923/17/8/974/xml
article pdf uploaded. 28 July 2025 10:45 CEST Version of Record https://www.mdpi.com/1999-4923/17/8/974/pdf
article supplementary file uploaded. 28 July 2025 10:45 CEST - https://www.mdpi.com/1999-4923/17/8/974#supplementary
article html file updated 28 July 2025 10:49 CEST Original file https://www.mdpi.com/1999-4923/17/8/974/html
Back to TopTop